Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze IRWD stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate IRWD investment potential.

What is IRWD stock price today?

Get real-time IRWD stock price, historical data, and price charts on Financhill. Track IRWD performance with our advanced analysis tools.

Is IRWD a good investment?

Evaluate IRWD investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy IRWD stock?

To buy IRWD stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of IRWD?

View detailed market capitalization data and company valuation metrics for IRWD on our comprehensive analysis page.

What is the P/E ratio of IRWD?

Use our fundamental analysis tools to view IRWD P/E ratio and compare valuation metrics with industry peers.

What are IRWD earnings?

View IRWD earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Ironwood Pharmaceuticals, Inc. 10K Form

Buy

IRWD
Ironwood Pharmaceuticals, Inc.

Last Price:

$3.73

Seasonality Move:

-12.63%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-09	10Q	IRWD/Ironwood Pharmaceuticals, Inc. Quarterly
2023-11-09	10Q	IRWD/Ironwood Pharmaceuticals, Inc. Quarterly
2023-08-09	10Q	IRWD/Ironwood Pharmaceuticals, Inc. Quarterly
2023-05-04	10Q	IRWD/Ironwood Pharmaceuticals, Inc. Quarterly
2022-11-03	10Q	IRWD/Ironwood Pharmaceuticals, Inc. Quarterly
2022-08-04	10Q	IRWD/Ironwood Pharmaceuticals, Inc. Quarterly

Receive IRWD News And Ratings

See the #1 stock for the next 7 days that we like better than IRWD

IRWD Financial Statistics

Sales & Book Value

Annual Sales:	$351.4M
Cash Flow:	$47.6M
Price / Cash Flow:	9.32
Annual Sales:	$-1.62
Price / Book:	0

Profitability

EPS (TTM):	0.15450
Net Income (TTM):	$29.5M
Gross Margin:	$349.4M
Return on Equity:	0%
Return on Assets:	8.16%

Ironwood Pharmaceuticals, Inc. Earnings Forecast

Key Ironwood Pharmaceuticals, Inc. Financial Ratios

The Gross Profit Margin over the past 18 years for IRWD is 99.43%.
The Selling, General & Administrative Expenses for IRWD have been equal to 41.06% of Gross Profit Margin.
The Research & Development expenses have been 31.13% of Revenue.
The Interest Expense is 3,753.86% of Operating Income.
The Net Earning history of IRWD is 0.25% of Total Revenues.
Per Share Earnings over the last 18 years have been positive in 8 years.

Ironwood Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	IRWD
CUSIP:	46333X
Website:	ironwoodpharma.com

Debt

Debt-to-Equity Ratio:	-2.26
Current Ratio:	1.13
Quick Ratio:	1.08

Price-to-Earnings

Trailing P/E Ratio:	678.18
Forward P/E Ratio:	8.11

IRWD Technical Analysis vs Fundamental Analysis

Buy

Ironwood Pharmaceuticals, Inc. (IRWD) is a Buy

Is Ironwood Pharmaceuticals, Inc. a Buy or a Sell?

Ironwood Pharmaceuticals, Inc. stock is rated a Buy

The current Ironwood Pharmaceuticals, Inc. [IRWD] share price is $3.73. The Score for IRWD is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.